GlucoTrack, Inc. (NasdaqCM: GCTK)
Health Care · Health Care Equipment & Supplies · US
$1.03
-14.88% today · -99.1% 1Y
GlucoTrack, Inc. (NasdaqCM: GCTK) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $822.09K and employs 15 people.
Over the last twelve months the share price has lost 99.1%, trading between 1.00 and 123.75.
Tweenvest scores GlucoTrack, Inc. across four factors: quality 26/100, value 41/100. Its strongest factor is value.
GCTK price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $822.09K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -112.77
- Dividend yield
- —
- Beta (5Y)
- 0.73
- 52-week high
- $123.75
- 52-week low
- $1.00
- Avg volume (3M)
- —
- Shares outstanding
- 798.14K
- Employees
- 15
- Next earnings
- —
About GlucoTrack, Inc.
GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
- ISIN
- US45824Q8042
- Founded
- 2001
- Listed since
- Apr 25, 2013
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Odyssey Health, Inc.OTCPK: ODYY | $903.79K | $0.01 | -1.20% |
| LogicMark, Inc.OTCPK: LGMK | $899.76K | $1.00 | -11.50% |
| TSP Advanced Technologies PlcOFEX: TSP | $892.27K | £0.00 | -10.00% |
| Profusa, Inc.NasdaqCM: PFSA | $860.02K | $1.42 | -15.98% |
| Nu-Med Plus, Inc.OTCPK: NUMD | $798.72K | $0.01 | -34.52% |
| Vivanza Biosciences LimitedBSE: 530057 | $698.49K | Rs1.69 | -0.59% |
| NanoEcho AB (publ)OM: NANECH | $611.31K | Skr0.01 | -40.37% |
| MultiCorp International, Inc.OTCPK: MCIC | $456.24K | $0.00 | -50.00% |
Figures last refreshed Oct 11, 2026.